Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Immunotherapy with Keytruda in Germany typically costs from $10,000 to $15,000. Total expenses depend on the medication dosage, the number of infusion cycles, and diagnostic requirements like PET/CT scans. In the US, similar procedures cost around $21,500 on average. Patients save around 42% compared to US prices. This range usually covers the drug, medical administration, and physician monitoring.
Bookimed Expert Insight: Choosing academic hospitals like the Medical Center in Solingen provides access to university-level research. German clinics often offer fixed-price diagnostics, such as PET/CT scans around $1,500. For lung cancer patients, specialists like Dr. Dieter Ukena at Bremen-Ost Clinic treat over 500 cases annually. This high volume ensures mastered protocols for managing complex immunotherapy side effects effectively.
Why choose Germany for immunotherapy with Keytruda (Pembrolizumab)?
Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics .
| Germany | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $10,000 | from $3,300 | from $15,000 |
As the leading global medical tourism platform, we have a huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Dr. Buhl specializes in treating brain metastases and vascular anomalies, combining clinical expertise with groundbreaking research.
Dr. Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.
Specializes in immunotherapy for tumor diseases, with expertise in Keytruda (Pembrolizumab). Recognized for molecular biology research in cancer treatment.
Dr. Weidmann heads the Hematology sector at Nordwest Clinic with 36 years of experience in blood disorder treatment.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Keytruda (pembrolizumab) is an immunotherapy drug that blocks the PD-1 protein on T-cells. This action prevents cancer cells from using PD-L1 ligands to signal the immune system to stand down. By removing this brake, the patient's own immune system can detect and destroy malignant cells.
Bookimed Expert Insight: German university hospitals like Bremen-Mitte or Solingen prioritize molecular diagnostics before starting Keytruda. This is crucial because therapy success depends on specific genetic markers. While US costs average $21,500, German centers offer this targeted precision for $10,000 to $15,000 per session.
Patient Consensus: Many patients describe the treatment as removing a cloaking device from tumors. They emphasize reporting new symptoms like shortness of breath or rashes immediately, as these signals indicate the immune system is overreacting.
Keytruda is commonly prescribed in Germany for advanced melanoma, non-small cell lung cancer, and renal cell carcinoma. German oncology centers also utilize this immunotherapy for triple-negative breast cancer, urothelial carcinoma, and tumors with specific biomarkers like MSI-H or dMMR regardless of location.
Bookimed Expert Insight: German oncology centers use interdisciplinary tumor boards to approve Keytruda protocols. Clinics like Medical Center in Solingen and Nordwest Clinic combine immunotherapy with molecular diagnostics. This ensures the drug only targets tumors with compatible PD-L1 markers, significantly improving therapy efficiency.
Patient Consensus: Patients emphasize the importance of genetic testing for MSI-H status before starting. Many report that while side effects are initially mild, long-term monitoring for autoimmune-like toxicity is essential.
Primary medical hubs for Keytruda treatment in Germany include elite university hospitals and certified centers in Frankfurt, Solingen, Bremen, Berlin, and Heidelberg. These facilities utilize multidisciplinary tumor boards and advanced biomarker testing to administer pembrolizumab for melanoma, lung, and hematological cancers.
Bookimed Expert Insight: While university hospitals in Berlin or Heidelberg draw international attention, centers like Bremen-Ost offer highly specialized lung cancer teams. Dr. Dieter Ukena treats over 500 immunotherapy cases annually, providing deep clinical experience with pembrolizumab side-effects. This focused volume often ensures faster adverse event management than general oncology departments.
Patient Consensus: Patients emphasize that success depends on having a complete biomarker workup ready before arrival. Many recommend starting treatment at a university center to design the protocol before transitioning to local clinics for regular infusions.
Patients receiving Keytruda typically experience manageable immune-related reactions, as the therapy activates the immune system to target cancer cells. Most symptoms are mild, but early detection of inflammatory responses in the lungs, colon, or endocrine system is vital for maintaining a successful treatment course.
Bookimed Expert Insight: German oncology centers like Nordwest Clinic and Medical Center Solingen prioritize molecular diagnostics to predict immune responses. This advanced screening often allows specialists such as Dr. Viola Fox to identify silent liver inflammation through bloodwork before physical symptoms even appear, ensuring safer therapeutic windows.
Patient Consensus: Many patients describe a deep fatigue that differs from regular tiredness and emphasize that side effects can suddenly appear even months after treatment ends.
German statutory health insurance covers Keytruda for medical indications approved by the European Medicines Agency (EMA). Insurers like Techniker Krankenkasse (TK) or AOK pay for treatment if an oncologist confirms medical necessity. Residents pay only a 10 euro co-payment per prescription under this universal framework.
Bookimed Expert Insight: Patient volume data suggests that large, multi-specialized centers like Nordwest Clinic (Krankenhaus) or Medical Center in Solingen possess more experience navigating high-cost reimbursement. These facilities treat over 60,000 patients annually and maintain specific certifications from the German Cancer Society. Choosing a certified interdisciplinary cancer center often speeds up the administrative pre-clearance process required for immunotherapy coverage.
Patient Consensus: Coverage depends heavily on using a diagnosis code that matches on-label indications. Patients strongly advise obtaining written confirmation from your Krankenkasse before starting therapy to ensure all costs are pre-cleared.
Keytruda is administered by medical professionals as an intravenous infusion or a subcutaneous injection. Typical schedules follow 3-week or 6-week cycles depending on the diagnosis. German oncology centers, like Northern West Clinic, utilize standardized protocols within certified outpatient units to ensure patient safety.
Bookimed Expert Insight: Patients in Germany often benefit from integrated care where immunotherapy is coordinated with molecular diagnostics. At Medical Center in Solingen, experts like Dr. Viola Fox manage complex drug therapies that frequently include Keytruda. This centralized approach reduces wait times between blood tests and the actual infusion.
Patient Consensus: Many patients recommend arriving early because the total appointment time includes lab results and pharmacy preparation. They noted that most side effects appear days after the infusion rather than during the session.